Skip to main content
. Author manuscript; available in PMC: 2022 May 9.
Published in final edited form as: ACS Infect Dis. 2021 Apr 23;7(6):1795–1808. doi: 10.1021/acsinfecdis.1c00101

Table 2.

Effects of TSB medium percentages and different media on the antibacterial activity of C10-KR8d, KR12, and human LL-37

Peptide Minimal inhibitory concentration (μM) against S. aureus
10% TSB 50% TSB 100% TSB 100% MHB
LL-37 50 >50 >50 >50
KR12 6.2 >50 >50 >50
C10-KR8d 1.6 3.1 3.1 3.1
MIC (μM) against E. coli
LL-37 1.6 6.2 6.25-12.5 6.2
KR12 1.6 3.1 >50 50
C10-KR8d 1.6 3.1 6.2 3.1